Optimized TPL6 Peptide Gel Exhibits Broad‐Spectrum Antimicrobial Activity and Effectively Treats Drug‐Resistant Wound Infections in Diabetic Mice
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202503863 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Wen-Chun Lin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Marine Research Station, Institute of Cellular and Organismic Biology, Academia Sinica, Jiaushi, Ilan, Taiwan. Hauptthemen laut MEDLINE: Wound Infection, Diabetes Mellitus, Experimental, Antimicrobial Peptides, Anti-Infective Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Ministry of Science and Technology, Ministry of Science and Technology (NSTC), Taiwan.
Abstract (Originalsprache)
Antibiotics are the primary treatments for diabetic foot infections (DFIs) but are often ineffective against severe, polymicrobial, or drug‐resistant microbial strains. Antimicrobial peptides (AMPs) offer broad‐spectrum activity, yet most fail in clinical translation due to known limitations. Here, TPL6 is developed, a TP4‐derived AMP with glycine‐rich segments deleted, yielding a variant with potent, robust antimicrobial activity and reduced cytotoxicity. TPL6 retains its α‐helical structure and activity under high glucose and salt, and after heat stress. It also does not induce microbial resistance after prolonged exposure. Formulated with adjuvants into a hydrogel, TPL6 gel restores activity in serum‐rich environments and outperforms Bacineocin ointment in simulated wound fluid. The gel further prevents formation and eradicates biofilms of multidrug‐resistant (MDR) pathogens. In ex vivo porcine skin and diabetic mouse wound models infected with MDR Staphylococcus aureus or Candida albicans , TPL6 gel shows superior therapeutic efficacy versus Bacineocin ointment and Canesten 1% cream. Thus, this study shows that structural modification and adjuvant‐based formulation of TPL6 can overcome key translational barriers that have hindered clinical application of AMPs, supporting its potential as an antibiotic‐free treatment for drug‐resistant wound infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Marine Research Station, Institute of Cellular and Organismic Biology, Academia Sinica, Jiaushi, Ilan, Taiwan.
- Academia Sinica Protein Clinic (ASPC), Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan.
- The iEGG and Animal Biotechnology Center and the Rong Hsing Research Center For Translational Medicine, National Chung Hsing University, Taichung, Taiwan.
ORCID-Profile: Jyh-Yih Chen
Förderung
- Ministry of Science and Technology
- Ministry of Science and Technology (NSTC), Taiwan
Zitieren
APA
Lin, W. C., You, M. F., Chen, Y. R., & Chen, J. Y. (2026). Optimized TPL6 Peptide Gel Exhibits Broad‐Spectrum Antimicrobial Activity and Effectively Treats Drug‐Resistant Wound Infections in Diabetic Mice. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202503863
Vancouver
Lin WC, You MF, Chen YR, Chen JY. Optimized TPL6 Peptide Gel Exhibits Broad‐Spectrum Antimicrobial Activity and Effectively Treats Drug‐Resistant Wound Infections in Diabetic Mice. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202503863
BibTeX
@article{Lin2026,
author = {Lin, Wen-Chun and You, Ming-Feng and Chen, Yun-Ru and Chen, Jyh-Yih},
title = {Optimized TPL6 Peptide Gel Exhibits Broad‐Spectrum Antimicrobial Activity and Effectively Treats Drug‐Resistant Wound Infections in Diabetic Mice},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202503863}
}
EUVIMED